Peel Hunt reiterated their buy rating on shares of Genedrive (LON:GDR) in a research report report published on Tuesday, March 20th. Peel Hunt currently has a GBX 152 ($2.15) price target on the stock.
GDR stock remained flat at $GBX 38.50 ($0.54) during mid-day trading on Tuesday. The company’s stock had a trading volume of 1,250 shares, compared to its average volume of 9,606. Genedrive has a 12 month low of GBX 25 ($0.35) and a 12 month high of GBX 44.50 ($0.63).
Genedrive (LON:GDR) last posted its earnings results on Tuesday, March 20th. The company reported GBX (9) (($0.13)) earnings per share (EPS) for the quarter. The company had revenue of GBX 263 million during the quarter. Genedrive had a negative net margin of 128.59% and a negative return on equity of 141.44%.
WARNING: “Peel Hunt Reiterates Buy Rating for Genedrive (GDR)” was published by Macon Daily and is the sole property of of Macon Daily. If you are reading this piece on another website, it was illegally stolen and reposted in violation of United States and international copyright laws. The original version of this piece can be accessed at https://macondaily.com/2018/04/12/genedrives-gdr-buy-rating-reaffirmed-at-peel-hunt-updated-updated-updated.html.
Genedrive Company Profile
Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia.
Receive News & Ratings for Genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genedrive and related companies with MarketBeat.com's FREE daily email newsletter.